Colony »

Cognition Therapeutics shares owned by Colony

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Colony from 13F filings

Historical chart of Colony investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Colony consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Colony

Quarter filed Position value Share count Share price at filing
2025-09-30 $20k 15k 1.35

More positions owned by Colony

Select Sector Spdr Tr Technology (XLK)
Apple (AAPL)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Ea Series Trust Ea Bridgeway Omn (BSVO)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p Ttl Stk (ITOT)
Dimensional Etf Trust Us High Profitab (DUHP)

View all positions for Colony

Top funds holding Cognition Therapeutics

BIOS Capital Management
Davenport & Co
Vanguard Group
Tang Capital Management
Chescapmanager
BlackRock
Jane Street
Renaissance Technologies
Geode Capital Management
Hilton Capital Management
Millennium Management
State Street Corporation
Voss Capital
Graham Capital Management
American Financial Group

View all funds holding Cognition Therapeutics